To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Meconium-staining of amniotic fluid (MSAF) is a physiological finding in many pregnancies, particularly postdates; however, its presence can have detrimental effects on the fetus. Chorioamnionitis is often associated with MSAF. If signs of infection are present with meconium-stained amniotic fluid, hypoxic stress should be reduced or even avoided to reduce the risk of hypoxic-induced encephalopathy. Meconium Aspiration Syndrome is a known complication that can potentially be very severe and lead to respiratory failure in the newborn. The risk of this can be reduced if labour is managed appropriately by avoiding extensive periods of hypoxic stress, such as prolonged periods of pushing or injudicious use of oxytocin infusion. The thickness of meconium should not be classified into significant or non-significant, as possible damage to a fetus can occur with the same amount of meconium regardless of the dilution in different amounts of amniotic fluid. Continuous electronic fetal heart monitoring should be recommended in the presence of meconium, and should be interpreted based on the application of fetal pathophysiology and wider clinical context, including progress of labour.
Placental insufficiency is the most common pathophysiological mechanism of reduced fetal growth, called fetal growth restriction (FGR), and dependong on the time of diagnosis, it is classified as early-onset (<32 weeks) and late-onset (>32 weeks). Two tools are used to determine time of birth to avoid intrauterine death and to minimize the risk of iatrogenic prematurity. Those tools assess the fetal high-priority central organs: the brain and the heart. The brain is assessed using the computerized CTG, which attempts to determine the short-term variation (STV), and the heart is assessed by ultrasound with Doppler examination to fetal blood flow indices to analyse several waveforms, and ‘Ductus Venosus A wave’ being a marker of fetal cardiac function. A fetus presenting in the antenatal period or during early labour with an increased baseline FHR, reduced variability with or without shallow decelerations, has already been exposed to a chronic intrauterine hypoxic environment and has exhausted the compensatory responses to withstand any further hypoxic stress. Therefore, such a fetus is not fit for labour.
Oligohydramnios may be found incidentally during routine ultrasound assessment, during evaluation of fetal well-being in complicated pregnancies, when evaluating decreased fetal movement, or a size to dates discrepancy. The primary method used to identify low amniotic fluid is trans abdominal ultrasound. A single deepest fluid pocket (SDP) with a width >1 cm, free of umbilical cord or fetal limbs should be measured. A four-quadrant measurement, amniotic fluid index, overestimates oligohydramnios without improving perinatal outcomes, thus SDP is the preferred method of measurement assessment of amniotic fluid. Fetal, placental, and maternal conditions can cause derangements in amniotic fluid production, leading to oligohydramnios. Gestational age at diagnosis can help to guide evaluation and narrow the possible causes after rupture of membranes is excluded. Timing of delivery is based on underlying cause and ongoing fetal assessment with recommended delivery for uncomplicated isolated oligohydramnios by the end of the 37th week.
This chapter first discusses the measurement of amniotic fluid and the technique of measuring the depth of amniotic pool. It then describes the causes, diagnosis, and treatment of both polyhydramnios and oligohydramnios. Amniotic fluid can be semi-quantified reliably using two-dimensional ultrasound measurement of the depth of amniotic pocket and presented with amniotic fluid index (AFI) or maximum vertical pool or pocket (MVP). Combination of clinical and ultrasound assessment often allows accurate diagnosis of the underlying causes of oligohydramnios and polyhydramnios, which are heterogeneous and are usually not treatable or reversible prenatally. The aim of management is to prevent the adverse consequences resulting from extreme deviations of amniotic fluid volume. In polyhydramnios, serial amnioreduction may help to relieve the maternal pressure symptoms. In oligohydramnios caused by ruptured membranes, serial amnioinfusion may be considered to prevent pulmonary hypoplasia. Both interventions are only supported by small and uncontrolled observational studies.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.